Nanochannel Electroporation as a Platform for Living Cell Interrogation in Acute Myeloid Leukemia

Effect of Nonendocytic Uptake of Nanoparticles on Human Bronchial Epithelial Cells

(2015) Xi Zhao et al.   ANALYTICAL CHEMISTRY

Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog

(2015) Xinmei Wang et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Single-Cell Detection of mRNA Expression Using Nanofountain-Probe Electroporated Molecular Beacons

(2015) Juan P. Giraldo-Vela et al.   Small

Targeted Delivery of Tumor Suppressor microRNA-1 by Transferrin- Conjugated Lipopolyplex Nanoparticles to Patient-Derived Glioblastoma Stem Cells

(2014) Xinmei Wang et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Insight into Mechanisms of Cellular Uptake of Lipid Nanoparticles and Intracellular Release of Small RNAs

(2014) Bo Yu et al.   PHARMACEUTICAL RESEARCH

Intronic miR-3151 Within BAALC Drives Leukemogenesis by Deregulating the TP53 Pathway

(2014) A.-K. Eisfeld et al.   Science Signaling

Nanofountain Probe Electroporation (NFP-E) of Single Cells

(2013) Wonmo Kang et al.   NANO LETTERS

Nonendocytic Delivery of Lipoplex Nanoparticles into Living Cells Using Nanochannel Electroporation

(2013) Pouyan E. Boukany et al.   Advanced Healthcare Materials

Lenalidomide-mediated enhanced translation of C/EBP -p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia

(2012) C. J. Hickey et al.   BLOOD

Nanochannel electroporation delivers precise amounts of biomolecules into living cells

(2011) Pouyan E. Boukany et al.   Nature Nanotechnology

MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1

(2009) R. Garzon et al.   BLOOD

Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

(2009) B. J. Wouters et al.   BLOOD

Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis

(2009) T Pabst et al.   BRITISH JOURNAL OF CANCER

Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome

(2009) Annika Dufour et al.   JOURNAL OF CLINICAL ONCOLOGY

Nanofountain-Probe-Based High-Resolution Patterning and Single-Cell Injection of Functionalized Nanodiamonds

(2009) Owen Loh et al.   Small

Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With,CEBPAMutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study

(2008) Guido Marcucci et al.   JOURNAL OF CLINICAL ONCOLOGY